Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 29% ± 11% | |
oligodendrocyte precursor cell | 13 studies | 37% ± 19% | |
astrocyte | 12 studies | 30% ± 14% | |
oligodendrocyte | 11 studies | 35% ± 13% | |
glutamatergic neuron | 10 studies | 42% ± 25% | |
macrophage | 9 studies | 27% ± 9% | |
adipocyte | 9 studies | 35% ± 9% | |
GABAergic neuron | 8 studies | 41% ± 22% | |
microglial cell | 8 studies | 28% ± 9% | |
fibroblast | 8 studies | 25% ± 7% | |
neuron | 6 studies | 36% ± 14% | |
interneuron | 6 studies | 43% ± 22% | |
epithelial cell | 6 studies | 31% ± 11% | |
smooth muscle cell | 6 studies | 20% ± 4% | |
B cell | 5 studies | 18% ± 2% | |
myeloid cell | 5 studies | 19% ± 3% | |
dendritic cell | 5 studies | 24% ± 10% | |
endothelial cell of lymphatic vessel | 5 studies | 26% ± 7% | |
natural killer cell | 5 studies | 18% ± 1% | |
pericyte | 5 studies | 23% ± 9% | |
non-classical monocyte | 4 studies | 18% ± 4% | |
granule cell | 4 studies | 39% ± 13% | |
amacrine cell | 4 studies | 22% ± 7% | |
retina horizontal cell | 4 studies | 19% ± 5% | |
cardiac muscle cell | 4 studies | 26% ± 3% | |
ciliated cell | 4 studies | 22% ± 5% | |
retinal rod cell | 4 studies | 21% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
GABAergic interneuron | 3 studies | 23% ± 4% | |
glial cell | 3 studies | 20% ± 2% | |
retinal ganglion cell | 3 studies | 26% ± 3% | |
mesothelial cell | 3 studies | 21% ± 4% | |
glycinergic amacrine cell | 3 studies | 18% ± 2% | |
hepatocyte | 3 studies | 36% ± 27% | |
muscle cell | 3 studies | 32% ± 14% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 35% ± 14% | |
alveolar macrophage | 3 studies | 35% ± 11% | |
monocyte | 3 studies | 27% ± 4% | |
lymphocyte | 3 studies | 22% ± 6% | |
basal cell | 3 studies | 30% ± 14% | |
mast cell | 3 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3449.00 | 21 / 21 | 100% | 12.52 | 504 / 504 |
esophagus | 100% | 3589.54 | 1445 / 1445 | 100% | 15.42 | 183 / 183 |
lung | 100% | 2980.46 | 578 / 578 | 100% | 15.02 | 1155 / 1155 |
ovary | 100% | 2678.94 | 180 / 180 | 100% | 12.28 | 430 / 430 |
breast | 100% | 3256.10 | 459 / 459 | 100% | 15.42 | 1117 / 1118 |
prostate | 100% | 2855.01 | 245 / 245 | 100% | 12.89 | 501 / 502 |
uterus | 100% | 2941.62 | 170 / 170 | 100% | 16.00 | 458 / 459 |
brain | 99% | 3370.45 | 2627 / 2642 | 100% | 18.44 | 705 / 705 |
stomach | 100% | 2406.90 | 359 / 359 | 99% | 10.75 | 284 / 286 |
intestine | 100% | 3259.38 | 966 / 966 | 99% | 10.18 | 523 / 527 |
thymus | 100% | 2699.01 | 653 / 653 | 99% | 12.63 | 600 / 605 |
kidney | 100% | 2086.47 | 89 / 89 | 99% | 13.31 | 891 / 901 |
pancreas | 99% | 1305.45 | 325 / 328 | 99% | 12.29 | 176 / 178 |
adrenal gland | 100% | 2546.36 | 258 / 258 | 96% | 9.24 | 221 / 230 |
skin | 100% | 2979.07 | 1809 / 1809 | 95% | 11.52 | 450 / 472 |
liver | 100% | 1218.38 | 226 / 226 | 93% | 6.64 | 376 / 406 |
adipose | 100% | 3511.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3708.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.20 | 29 / 29 |
muscle | 100% | 4755.22 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2971.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.27 | 1 / 1 |
heart | 96% | 1956.44 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1779.10 | 850 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 4.37 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0034657 | Cellular component | GID complex |
GO_0035580 | Cellular component | specific granule lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | ARMC8 |
Protein name | Armadillo repeat containing 8 Armadillo repeat-containing protein 8 |
Synonyms | S863-2 hCG_1818291 |
Description | FUNCTION: Component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1. . |
Accessions | ENST00000471453.5 [Q8IUR7-6] B7Z637 H7C4J4 C9J8P8 ENST00000469860.2 C9J625 ENST00000468560.1 ENST00000470821.5 H7C5B7 C9JBY2 ENST00000470549.6 C9J2I1 ENST00000461600.5 G5E9V6 ENST00000471709.5 ENST00000358441.6 [Q8IUR7-6] ENST00000481646.5 [Q8IUR7-2] C9JAA7 ENST00000489213.5 Q8IUR7 ENST00000461822.5 [Q8IUR7-8] G5E9V7 ENST00000466749.5 ENST00000538260.5 [Q8IUR7-7] ENST00000464181.2 H7C5H2 ENST00000485396.5 ENST00000463485.5 ENST00000469044.6 [Q8IUR7-1] ENST00000491704.5 [Q8IUR7-3] |